ATE544865T1 - Assays für den zusammenbau von ebola-virus- nukleocapsiden - Google Patents

Assays für den zusammenbau von ebola-virus- nukleocapsiden

Info

Publication number
ATE544865T1
ATE544865T1 AT03751792T AT03751792T ATE544865T1 AT E544865 T1 ATE544865 T1 AT E544865T1 AT 03751792 T AT03751792 T AT 03751792T AT 03751792 T AT03751792 T AT 03751792T AT E544865 T1 ATE544865 T1 AT E544865T1
Authority
AT
Austria
Prior art keywords
assembly
glycosylation
assay
ebola virus
relates
Prior art date
Application number
AT03751792T
Other languages
English (en)
Inventor
Gary Nabel
Yue Huang
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE544865T1 publication Critical patent/ATE544865T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
AT03751792T 2002-07-12 2003-07-11 Assays für den zusammenbau von ebola-virus- nukleocapsiden ATE544865T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39587602P 2002-07-12 2002-07-12
US45131703P 2003-02-28 2003-02-28
PCT/US2003/021757 WO2004007747A2 (en) 2002-07-12 2003-07-11 Assays for assembly of ebola virus nucleocapsids

Publications (1)

Publication Number Publication Date
ATE544865T1 true ATE544865T1 (de) 2012-02-15

Family

ID=30118554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03751792T ATE544865T1 (de) 2002-07-12 2003-07-11 Assays für den zusammenbau von ebola-virus- nukleocapsiden

Country Status (7)

Country Link
US (1) US7449190B2 (de)
EP (1) EP1543165B1 (de)
JP (1) JP2005533111A (de)
AT (1) ATE544865T1 (de)
AU (1) AU2003269903B2 (de)
CA (1) CA2492068C (de)
WO (1) WO2004007747A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682618B2 (en) * 2001-11-07 2010-03-23 The United States Of America As Represented By The Secretary Of The Army Generation of virus-like particles and use as panfilovirus vaccine
US20100143409A1 (en) * 2001-11-07 2010-06-10 Sina Bavari Generation of virus-like particles and use as panfilovirus vaccines
WO2013107290A1 (en) * 2012-01-20 2013-07-25 The Government of the Hong Kong Special Administrative Region of the People's Republic of China A novel paramyxovirus and uses thereof
WO2021188586A1 (en) * 2020-03-16 2021-09-23 Board Of Regents, The University Of Texas System Method of treating viral infections with hexose type monosaccharides and analogs thereof
WO2023004307A1 (en) * 2021-07-19 2023-01-26 Epivax, Inc. T cell epitopes and related compositions useful in the prevention and treatment of respiratory syncytial virus infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109496A (en) 1977-12-20 1978-08-29 Norris Industries Trapped key mechanism
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
US5679342A (en) * 1987-11-18 1997-10-21 Chiron Corporation Hepatitis C virus infected cell systems
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
GB9615726D0 (en) * 1996-07-26 1996-09-04 Medical Res Council Anti-viral agent 11
AU5556799A (en) * 1998-08-12 2000-03-06 University Of Virginia Patent Foundation Assay for assembly of herpes simplex virus capsid
WO2003039477A2 (en) * 2001-11-07 2003-05-15 U.S. Army Medical Research Institute Of Infections Diseases Department Of The Army Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding

Also Published As

Publication number Publication date
EP1543165A2 (de) 2005-06-22
US7449190B2 (en) 2008-11-11
WO2004007747A3 (en) 2004-07-01
CA2492068A1 (en) 2004-01-22
EP1543165B1 (de) 2012-02-08
EP1543165A4 (de) 2007-05-09
CA2492068C (en) 2013-02-26
AU2003269903B2 (en) 2009-07-23
US20050180993A1 (en) 2005-08-18
JP2005533111A (ja) 2005-11-04
WO2004007747A2 (en) 2004-01-22
AU2003269903A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
ATE396739T1 (de) Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten
ECSP045300A (es) Antígenos virales
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
DE60126349D1 (de) Rekombinantes nukleoprotein von newcastle-krankheitsvirus als markierungsimpfstoff
NO20082743L (no) Kimaere virus som fremviser ikke-native overflateproteiner samt anvendelse derav
NO20011282D0 (no) Nytt influensavirusvaksinepreparat
EA200900033A1 (ru) Вакцины против малярии
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
ATE309821T1 (de) Influenzavirus-impfstoffzusammensetzung
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
DK1516058T3 (da) Rekombinante mæslingevira, som udtrykker epitoper på antigener af RNA-vira, samt anvendelse af de rekombinante vira til fremstilling af vacciner
DE60233061D1 (de) Alphavirus replikon-vektorsysteme
DE60227268D1 (de) Knockout-mutante von vaccinia-virus und verwendung davon
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
DE69936337D1 (de) Verfahren zur entwicklung von einem hiv impfstoff
EP1543165A4 (de) Assays für den zusammenbau von ebola-virus-nukleocapsiden
ATE419008T1 (de) Adjuvante zusammensetzung und anwendungsverfahren dafür
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
DK1951300T3 (da) Ændring af Th1/Th2-balancen i split-influenzavacciner med adjuvanser
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
AR057225A1 (es) Vacunas marcadas contra el virus de la diarrea virica bovina
CO5050367A1 (es) Nueva composicion
NO950211L (no) Vaksiner mot metazo-parasitter
BR0114709A (pt) Métodos para a preparação de bifenil isoxazol sulfonamidas
ATE521640T1 (de) Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen